Cataloguing of potential HIV susceptibility factors during the menstrual cycle of pig-tailed macaques by using a systems biology approach

Journal of Virology

Volumn 89, Issue 18, 2015, Pages 9167-9177

  Vishwanathan, S A ^a   Burgener, A ^b,d,f   Bosinger, S E ^e   Tharp, G K ^e   Guenthner, P C ^a   Patel, N B ^e   Birse, K ^b   Hanson, D L ^a   Westmacott, G R ^c   Henning, T R ^a   Radzio, J ^a   Garcia Lerma, J G ^a   Ball, T B ^b,d   McNicholl, J M ^a   Kersha, E N ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d JC Wilt Infectious Disease Research Centre   (Canada)

^e EMORY UNIVERSITY   (United States)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN D; BETA DEFENSIN 2; BETA DEFENSIN 3; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR I; EOTAXIN; GLUCOSE 6 PHOSPHATE ISOMERASE; GRANULOCYTE COLONY STIMULATING FACTOR; INTEGRIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; KALLIKREIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MOESIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SURFACTANT PROTEIN D; SYNDECAN; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; ANTIVIRUS AGENT;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLICULAR PHASE; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION SENSITIVITY; LUTEAL PHASE; MACACA NEMESTRINA; MENSTRUAL CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RNA HYBRIDIZATION; SYSTEMS BIOLOGY; TANDEM MASS SPECTROMETRY; TRANSCRIPTOMICS; VAGINA EPITHELIUM; ANIMAL; DISEASE PREDISPOSITION; ESTRUS CYCLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INNATE IMMUNITY; RISK FACTOR; TRANSMISSION; VAGINA;

ANIMALS; ANTIVIRAL AGENTS; DISEASE SUSCEPTIBILITY; ESTROUS CYCLE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; MACACA NEMESTRINA; RISK FACTORS; SYSTEMS BIOLOGY; VAGINA;

EID: 84940530336     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00263-15     Document Type: Article

References (54)

1. Powers KA, Poole C, Pettifor AE, Cohen MS. 2008. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 8:553-563. http://dx.doi.org/10.1016/S1473-3099(08)70156-7.
2. Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. 2014. Estimating per-act HIV transmission risk: a systematic review. AIDS 28: 1509-1519. http://dx.doi.org/10.1097/QAD.0000000000000298.
3. Hladik F, McElrath MJ. 2008. Setting the stage: host invasion by HIV. Nat Rev Immunol 8:447-457. http://dx.doi.org/10.1038/nri2302.
4. WiraCR,FaheyJV. 2008.Anewstrategy to understandhowHIVinfectswomen: identification of a window of vulnerability during the menstrual cycle. AIDS 22: 1909-1917. http://dx.doi.org/10.1097/QAD.0b013e3283060ea4.
5. Hickey DK, Patel MV, Fahey JV, Wira CR. 2011. Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol 88:185-194. http://dx.doi.org/10.1016/j.jri.2011.01.005.
6. Kersh EN, Henning T, Vishwanathan SA, Morris M, Butler K, Adams DR, Guenthner P, Srinivasan P, Smith J, Radzio J, Garcia-Lerma JG, Dobard C, Heneine W, McNicholl J. 2014. SHIV susceptibility changes during the menstrual cycle of pigtail macaques. J Med Primatol 43:310-316. http://dx.doi.org/10.1111/jmp.12124.
7. Vishwanathan SA, Guenthner PC, Lin CY, Dobard C, Sharma S, Adams DR, Otten RA, Heneine W, Hendry RM, McNicholl JM, Kersh EN. 2011. High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J Acquir Immune Defic Syndr 57:261-264. http://dx.doi.org/10.1097/QAI.0b013e318220ebd3.
8. Sodora DL, Gettie A, Miller CJ, Marx PA. 1998. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses 14(Suppl 1):S119-S123.
9. Sheffield JS, Wendel GD, Jr, McIntire DD, Norgard MV. 2009. The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression. Reprod Sci 16:20-31. http://dx.doi.org/10.1177/1933719108325510.
10. Hadzic SV, Wang X, Dufour J, Doyle L, Marx PA, Lackner AA, Paulsen DB, Veazey RS. 2014. Comparison of the vaginal environment of Macaca mulatta and Macaca nemestrina throughout the menstrual cycle. Am J Reprod Immunol 71:322-329. http://dx.doi.org/10.1111/aji.12201.
11. Poonia B, Walter L, Dufour J, Harrison R, Marx PA, Veazey RS. 2006. Cyclic changes in the vaginal epithelium of normal rhesus macaques. J Endocrinol 190:829-835. http://dx.doi.org/10.1677/joe.1.06873.
12. Burgener A, Tjernlund A, Kaldensjo T, Abou M, McCorrister S, Westmacott GR, Mogk K, Ambrose E, Broliden K, Ball B. 2013. A systems biology examination of the human female genital tract shows compartmentalization of immune factor expression. J Virol 87:5141-5150. http://dx.doi.org/10.1128/JVI.03347-12.
13. Henning TR, Butler K, Hanson D, Sturdevant G, Ellis S, Sweeney EM, Mitchell J, Deyounks F, Phillips C, Farshy C, Fakile Y, Papp J, Evan Secor W, Caldwell H, Patton D, McNicholl JM, Kersh E. 2014. Increased susceptibility to vaginal simian/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis. J Infect Dis 210:1239-1247. http://dx.doi.org/10.1093/infdis/jiu240.
14. Radzio J, Hanley K, Mitchell J, Ellis S, Deyounks F, Jenkins LT, Hanson D, Heneine W, Garcia-Lerma JG. 2014. Physiologic doses of depotmedroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques. AIDS 28:1431-1439. http://dx.doi.org/10.1097/QAD.0000000000000294.
15. Saltzman W, Schultz-Darken NJ, Scheffler G, Wegner FH, Abbott DH. 1994. Social and reproductive influences on plasma cortisol in female marmoset monkeys. Physiol Behav 56:801-810. http://dx.doi.org/10.1016/0031-9384(94)90246-1.
16. Burgener A, Mogk K, Westmacott G, Plummer F, Ball B, Broliden K, Hasselrot K. 2012. Salivary basic proline-rich proteins are elevated in HIV-exposed seronegative men who have sex with men. AIDS 26:1857-1867. http://dx.doi.org/10.1097/QAD.0b013e328357f79c.
17. Storey JD, Tibshirani R. 2003. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100:9440-9445. http://dx.doi.org/10.1073/pnas.1530509100.
18. Smyth GK, Michaud J, Scott HS. 2005. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21:2067-2075. http://dx.doi.org/10.1093/bioinformatics/bti270.
19. Nadon R, Shoemaker J. 2002. Statistical issues with microarrays: processing and analysis. Trends Genet 18:265-271. http://dx.doi.org/10.1016/S0168-9525(02)02665-3.
20. Baldi P, Long AD. 2001. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 17:509-519. http://dx.doi.org/10.1093/bioinformatics/17.6.509.
21. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545-15550. http://dx.doi.org/10.1073/pnas.0506580102.
22. Rotger M, Dalmau J, Rauch A, McLaren P, Bosinger SE, Martinez R, Sandler NG, Roque A, Liebner J, Battegay M, Bernasconi E, Descombes P, Erkizia I, Fellay J, Hirschel B, Miro JM, Palou E, Hoffmann M, Massanella M, Blanco J, Woods M, Gunthard HF, de Bakker P, Douek DC, Silvestri G, Martinez-Picado J, Telenti A. 2011. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest 121:2391-2400. http://dx.doi.org/10.1172/JCI45235.
23. Wira CR, Patel MV, Ghosh M, Mukura L, Fahey JV. 2011. Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol 65:196-211. http://dx.doi.org/10.1111/j.1600-0897.2011.00970.x.
24. Bowman EP, Kuklin NA, Youngman KR, Lazarus NH, Kunkel EJ, Pan J, Greenberg HB, Butcher EC. 2002. The intestinal chemokine thymusexpressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med 195:269-275. http://dx.doi.org/10.1084/jem.20010670.
25. Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, Wilson SJ, Schoggins JW, Rice CM, Yamashita M, Hatziioannou T, Bieniasz PD. 2013. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502:563-566. http://dx.doi.org/10.1038/nature12653.
26. Veazey RS. 2008. Microbicide safety/efficacy studies in animals: macaques and small animal models. Curr Opin HIV AIDS 3:567-573. http://dx.doi.org/10.1097/COH.0b013e32830891bb.
27. Kramer HB, Lavender KJ, Qin L, Stacey AR, Liu MK, di Gleria K, Simmons A, Gasper-Smith N, Haynes BF, McMichael AJ, Borrow P, Kessler BM. 2010. Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection. PLoS Pathog 6:e1000893. http://dx.doi.org/10.1371/journal.ppat.1000893.
28. Morrow MP, Grant A, Mujawar Z, Dubrovsky L, Pushkarsky T, Kise-lyeva Y, Jennelle L, Mukhamedova N, Remaley AT, Kashanchi F, Sviridov D, Bukrinsky M. 2010. Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1. Mol Pharmacol 78:215-225. http://dx.doi.org/10.1124/mol.110.065029.
29. Dunkelberger JR, Song WC. 2010. Complement and its role in innate and adaptive immune responses. Cell Res 20:34-50. http://dx.doi.org/10.1038/cr.2009.139.
30. Elia C, Cassol E, Sidenius N, Blasi F, Castagna A, Poli G, Alfano M. 2007. Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion. J Leukoc Biol 82:1212-1220.http://dx.doi.org/10.1189/jlb.0407251.
31. Burgener A, Rahman S, Ahmad R, Lajoie J, Ramdahin S, Mesa C, Brunet S, Wachihi C, Kimani J, Fowke K, Carr S, Plummer F, Ball TB. 2011. Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female sex workers. J Proteome Res 10:5139-5149. http://dx.doi.org/10.1021/pr200596r.
32. Rahman S, Rabbani R, Wachihi C, Kimani J, Plummer FA, Ball TB, Burgener A. 2013. Mucosal serpin A1 and A3 levels in HIV highly exposed sero-negative women are affected by the menstrual cycle and hormonal contraceptives but are independent of epidemiological confounders.AmJ Reprod Immunol 69:64-72. http://dx.doi.org/10.1111/aji.12014.
33. Aboud L, Ball TB, Tjernlund A, Burgener A. 2014. The role of serpin and cystatin antiproteases in mucosal innate immunity and their defense against HIV. Am J Reprod Immunol 71:12-23. http://dx.doi.org/10.1111/aji.12166.
34. Saba E, Origoni M, Taccagni G, Ferrari D, Doglioni C, Nava A, Lisco A, Grivel JC, Margolis L, Poli G. 2013. Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle. Mucosal Immunol 6:1081-1090.
35. Solis M, Nakhaei P, Jalalirad M, Lacoste J, Douville R, Arguello M, Zhao T, Laughrea M, Wainberg MA, Hiscott J. 2011. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. J Virol 85:1224-1236. http://dx.doi.org/10.1128/JVI.01635-10.
36. Zhang X, Yu J, Kuzontkoski PM, Zhu W, Li DY, Groopman JE. 2012. Slit2/Robo4 signaling modulates HIV-1 gp120-induced lymphatic hyperpermeability. PLoS Pathog 8:e1002461. http://dx.doi.org/10.1371/journal.ppat.1002461.
37. Anand AR, Zhao H, Nagaraja T, Robinson LA, Ganju RK. 2013. N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. Retrovirology 10:2. http://dx.doi.org/10.1186/1742-4690-10-2.
38. Bosinger SE, Li Q, Gordon SN, Klatt NR, Duan L, Xu L, Francella N, Sidahmed A, Smith AJ, Cramer EM, Zeng M, Masopust D, Carlis JV, Ran L, Vanderford TH, Paiardini M, Isett RB, Baldwin DA, Else JG, Staprans SI, Silvestri G, Haase AT, Kelvin DJ. 2009. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 119:3556-3572.
39. Barrero-Villar M, Cabrero JR, Gordon-Alonso M, Barroso-Gonzalez J, Alvarez-Losada S, Munoz-Fernandez MA, Sanchez-Madrid F, Valenzuela-Fernandez A. 2009. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes. J Cell Sci 122:103-113. http://dx.doi.org/10.1242/jcs.035873.
40. Lim JK, Lu W, Hartley O, DeVico AL. 2006. N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variant. J Leukoc Biol 80:1395-1404. http://dx.doi.org/10.1189/jlb.0406290.
41. Moriuchi H, Moriuchi M, Fauci AS. 2000. Cathepsin G, a neutrophilderived serine protease, increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infection. J Virol 74:6849-6855. http://dx.doi.org/10.1128/JVI.74.15.6849-6855.2000.
42. Klebanoff SJ. 2005. Myeloperoxidase: friend and foe. J Leukoc Biol 77:598-625. http://dx.doi.org/10.1189/jlb.1204697.
43. Kanlaya R, Pattanakitsakul SN, Sinchaikul S, Chen ST, Thongboonkerd V. 2010. Vimentin interacts with heterogeneous nuclear ribonucleoproteins and dengue nonstructural protein 1 and is important for viral replication and release. Mol Biosyst 6:795-806. http://dx.doi.org/10.1039/b923864f.
44. Thomas EK, Connelly RJ, Pennathur S, Dubrovsky L, Haffar OK, Bukrinsky MI. 1996. Anti-idiotypic antibody to the V3 domain of gp120 binds to vimentin: a possible role of intermediate filaments in the early steps of HIV-1 infection cycle. Viral Immunol 9:73-87. http://dx.doi.org/10.1089/vim.1996.9.73.
45. Shaw JL, Petraki C, Watson C, Bocking A, Diamandis EP. 2008. Role of tissue kallikrein-related peptidases in cervical mucus remodeling and host defense. Biol Chem 389:1513-1522.
46. Yamasaki K, Schauber J, Coda A, Lin H, Dorschner RA, Schechter NM, Bonnart C, Descargues P, Hovnanian A, Gallo RL. 2006. Kallikreinmediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J 20:2068-2080. http://dx.doi.org/10.1096/fj.06-6075com.
47. Pham CT. 2006. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 6:541-550. http://dx.doi.org/10.1038/nri1841.
48. Bobardt MD, Saphire AC, Hung HC, Yu X, Van der Schueren B, Zhang Z, David G, Gallay PA. 2003. Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity 18:27-39. http://dx.doi.org/10.1016/S1074-7613(02)00504-6.
49. de Witte L, Bobardt M, Chatterji U, Degeest G, David G, Geijtenbeek TB, Gallay P. 2007. Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc Natl Acad Sci U S A 104:19464-19469. http://dx.doi.org/10.1073/pnas.0703747104.
50. Lima RG, Van Weyenbergh J, Saraiva EM, Barral-Netto M, Galvao-Castro B, Bou-Habib DC. 2002. The replication of human immunodeficiency virus type 1 in macrophages is enhanced after phagocytosis of apoptotic cells. J Infect Dis 185:1561-1566. http://dx.doi.org/10.1086/340412.
51. Ansari AA, Reimann KA, Mayne AE, Takahashi Y, Stephenson ST, Wang R, Wang X, Li J, Price AA, Little DM, Zaidi M, Lyles R, Villinger F. 2011. Blocking of alpha4beta7 gut-homing integrin during acute infection leads to decreased plasma and gastrointestinal tissue viral loads in simian immunodeficiency virus-infected rhesus macaques. J Immunol 186:1044-1059. http://dx.doi.org/10.4049/jimmunol.1003052.
52. Ghosh M, Fahey JV, Shen Z, Lahey T, Cu-Uvin S, Wu Z, Mayer K, Wright PF, Kappes JC, Ochsenbauer C, Wira CR. 2010. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One 5:e11366. http://dx.doi.org/10.1371/journal.pone.0011366.
53. Modi WS, Goedert JJ, Strathdee S, Buchbinder S, Detels R, Donfield S, O'Brien SJ, Winkler C. 2003. MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. AIDS 17:2357-2365. http://dx.doi.org/10.1097/00002030-200311070-00011.
54. Vicenzi E, Alfano M, Ghezzi S, Gatti A, Veglia F, Lazzarin A, Sozzani S, Mantovani A, Poli G. 2000. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1. J Leukoc Biol 68:405-412.